In studying prion diseases, Alzheimer’s disease, tauopathies, and alpha-synuclein pathology, transmission of patient-derived proteopathic seeds into humanised mice accelerates pathological cascades and produces relevant strong phenotypes and/or pathology [93–98]. Here, SNCA is linked to early-onset autosomal dominant Alzheimer disease.